Apotex Health Corp (APTX.TO) — Quality & forensics
As of 2026-10-06 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 50
- Quality 59
- Growth 35
- Balance sheet 35
- Cash quality 66
- Capital allocation 46
- Momentum 34
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the grey zone (1.81–2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the APTX.TO chart & overview
FAQ · from the current data · as of 2026-10-06
Quick answers
What is Apotex Health Corp's Closelooknet quality reading?
The composite reads 46/100 across 7 modules, as of 2026-10-06: valuation 50, quality 59, growth 35, balance sheet 35, cash quality 66, capital allocation 46, momentum 34. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Apotex Health Corp's Altman Z-Score?
2.07, which sits in the grey zone (1.81–2.99) as of 2026-10-06. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Apotex Health Corp's Piotroski F-Score?
7 of 9, as of 2026-10-06. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Apotex Health Corp's Beneish M-Score indicate?
-3.00 — below the −1.78 manipulation-risk threshold, as of 2026-10-06. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- AMRX Amneal Pharmaceuticals, Inc. Class A Common Stockindustry
- ALM.MC Almirall S.A.industry
- FAGR.BR Fagron NVindustry
- RDY Dr. Reddy’s Laboratories Ltd ADRindustry
- SFZN.SW Siegfried Holding Ltdindustry
- HCM.L HUTCHMED China Ltdindustry
- UTHR United Therapeutics Corporationindustry
- TEVA Teva Pharma Industries Ltd ADRindustry
- PRGO Perrigo Company PLCindustry
- VTRS Viatris Incindustry
- BHC.TO Bausch Health Companies Incindustry
- HIMS Hims Hers Health Incindustry
- TAK Takeda Pharmaceutical Co Ltd ADRindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- LNTH Lantheus Holdings Incindustry
- ALKS Alkermes Plcindustry
- DMP.DE Dermapharm Holding SEindustry
- ZTS Zoetis Incindustry
- ELAN Elanco Animal Healthindustry